Early Clinical Stages of Nonseminomatous Testis Cancer Evaluation of the Primary Treatment and Follow-up Procedures of the Swenoteca Project

References

• Cavallin-Ståhl E, Dahl O, Høiem L, Ous S, Ranstam J, Wahlqvist L, Ødegaard A. How reliable are non-invasive methods to establish complete remission (CR) of abdominal metastases after chemotherapy in non-seminomatous germ cell testicular cancer (NSGT)?. Abstracts, 3rd European Conf on Clinical Oncology, Stockholm, 1985; 174
   Google Scholar
• Cox D R. Analysis of binary data. Chapman and Hall, London 1970, Section 6.6
   Google Scholar
• Einhorn L H, Donohue J P. Combination chemotherapy with cisdiamminedichloroplatinum, vinblastine, and bleomycin in disseminated testicular cancer. Ann Intern Med 1977; 87: 293–298
   PubMed Web of Science ®Google Scholar
• Forsberg L, Dale L, Høiem L, Magnusson A, Mikulowski P, Olsson A M, Ous S, Stenwig A E. Computed tomography in early stages of testicular carcinoma. Acta Radiologica Diagnosis 1986; 27: 569–574
   PubMedGoogle Scholar
• Fosså S D, Ous S, Åbyholm T, Loeb M. Post-treatment fertility in patients with testicular cancer. Br J Urol 1985; 57: 204–209
   PubMedGoogle Scholar
• Freedman L S, Parkinson M C, Jones W G, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone. Lancet 1987; II: 294–298
   Google Scholar
• Fung C Y, Kalish L A, Brodsky G L, Richie J P, Garnick M B. Stage I nonseminomatous germ cell testicular tumour: Prediction of metastatic potential by primary histopathology. J Clin Oncol 1988; 6: 1467–1473
   PubMed Web of Science ®Google Scholar
• Halme A, Kellekumpu-Lehtinen P, Lehtonen T. Trends in incidence and results of treatment of testicular germ cell tumours in Finland 1972–1983. Acta Oncologica 1989; 28: 777–783
   PubMed Web of Science ®Google Scholar
• Harmer M H. TNM classification of malignant tumours. Union Internationale Contre le Cancer, Geneva 1978; 122–125
   Google Scholar
• Horwich A, Brada M, Nicholls J, Jay G, Hendry W F, Dearnalay D, Peckham M J. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol 1989; 25: 177–184
   PubMedGoogle Scholar
• Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham M J. Prognostic factors in stage I non-seminomatous germ-cell testicular tumours managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 1986; 4: 1031–36
   PubMed Web of Science ®Google Scholar
• Kalbfleisch J D, Prentice R L. The statistical analysis of failure time data. Wiley, New York 1980
   Google Scholar
• Klepp O. Risk indicators in stage 1 testicular teratoma. Lancet 1989; I: 506
   Google Scholar
• Klepp O, Olsson A M, Henrikson H, Aass N, Dahl O, Stenwig A E, Persson B E, Cavallin-Ståhl E, Fosså S D, Wahlqvist L. Prognostic factors in clinical stage I nonseminomatous germ cell tumours of the testis; Multivariate analysis of a prospective multicentre study (SWENOTECA). J Clin Oncol 1990; 8: 509–518
   PubMed Web of Science ®Google Scholar
• Klepp O, Flodgren P, Maartman-Moe H, Lindholm C E, Unsgaard B, Teigum H, Fosså S D, Paus E. for the Swedish-Norwegian Testicular Cancer Project (SWENOTECA). Early clinical stages (CS1, CS1Mk+ and CS2A) of nonseminomatous testis cancer: Value of pre- and post-orchiectomy serum tumour marker information in prediction of retroperitoneal lymph node metastases. Ann Oncol 1990; 1: 281–288
   PubMed Web of Science ®Google Scholar
• Lien H H, Stenwig A E, Ous S, Fosså S D. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumour. Acta Radiol Diagn 1986; 27: 199–203
   PubMedGoogle Scholar
• Mostofi F K, Sobin L H. Histological typing of testis tumours. International histological classification of tumours, no. 16. World Health Organization, Geneva 1977; 1–39
   Google Scholar
• Pizzocaro G, Salvioni R, Zanoni F. Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol 1985; 134: 485–489
   PubMed Web of Science ®Google Scholar
• Pizzocaro G, Zanoni F, Salvioni R, Milani A, Piva L, Pilotti S. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumours of the testis. J Urol 1987; 138: 1393–1396
   PubMed Web of Science ®Google Scholar
• Rowland R G, Weisman D, Williams S D, Einhorn L H, Klatte E C, Donohue J P. Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumours. J Urol 1982; 127: 718–720
   PubMed Web of Science ®Google Scholar
• Schultz H P, Arends J, Barlebo H, Brincker H, Strøyer-Christoffersen I, Engelholm S A, Gammelgaard P A, Genster H, Hansen H H, Jacobsen Krag G, Skov Jensen T, Lund F, von der Mase H, Nørgaard-Pedersen B, Olsen J, Pedersen M, Rørth M, Nielsen Sandberg E, Sell A, Starklint H, Steenholdt S, Svennekjær I L, Søgaard H, Sørensen B L, Thybo E, Væth M, Walbom-Jørgensen S. Testicular carcinoma in Denmark 1976–1980; Stage and selected clinical parameters at presentation. Acta Radiol Oncol 1984; 23: 249–253
   PubMed Web of Science ®Google Scholar
• Weissbach L, Boedefeld E A, Bussar-Maatz R, Kleinschmidt K, Testicular Tumour Study Group. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?. EORTC Genitourinary Group Monograph 5: Progress and controversies in oncological urology II. Alan R. Liss Inc., 1988; 407–416
   Google Scholar
• Williams D, Stablein D M, Einhorn L H, Muggia F M, Weiss R B, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317: 1433–1438
   PubMed Web of Science ®Google Scholar